Edoxaban,a new oral anticoagulant,as a direct factor Xa inhibitor,has the advantages of rapid oral absorption,small interaction between drug and food,no routine monitoring of coagulation indicators,good tolerance,safety and compliance.Although it has been on the market late,it is more and more widely used in the clinical practice of cardiovascular disease.This article reviews the research progress of edoxaban in cardiovascular disease.
EdoxabanNon-valvular atrial fibrillationNon-vitamin K antagonist oral anticoagulantsCardiovascular disease
维普
万方数据
